Workflow
Schaeffers Research
icon
Search documents
Blue-Chip Banking Giant Slated to Report Earnings
Schaeffers Research· 2024-01-10 16:54
JPMorgan Chase & Co (NYSE:JPM) will report fourth-quarter financial results before the open on Friday, Jan. 12. The blue-chip bank concern has an upbeat post-earnings past, boasting gains in its last five next-day sessions in the red. Regardless of direction, JPM averaged a 3.3% next-day return over the last two years, which is lower than the 4.1% swing options players are pricing in this time around.  Last seen 0.7% lower to trade at $169.46, JPMorgan Chase stock has largely managed to brush off the New Ye ...
Lennar Stock Pops on Hiked Dividend, Buyback Program
Schaeffers Research· 2024-01-10 15:43
Lennar Corp (NYSE:LEN) lifted its annual dividend to $2 per share from $1.50, and also raised its stock buyback program by $5 billion. LEN was last seen up 3.6% to trade at $153.56, and earlier came even closer to its Dec. 15 all-time high of $156, after staging a bounce off the $144 level last week. Over the past 12 months, the security added almost 60%.The options pits are seeing increased bullish activity in response. So far today, 2,350 calls have been traded, or double the intraday average amount. Most ...
Analyst: Netflix Can't Meet Lofty Expectations
Schaeffers Research· 2024-01-09 14:04
Citigroup downgraded shares of streaming giant Netflix Inc (NASDAQ:NFLX) to "neutral" from "buy," citing unrealistic expectations from Wall Street. Specifically, the analyst said that investors' expectations of a 25% jump in the two-year stacked growth rate is unlikely to happen in the final quarter of 2024. Conversely, BMO initiated coverage on NFLX with an "outperform" rating and a $566 price target, while TD Cowen raised its target price to $565 from $500. Coming into today, 22 analysts rated the equity ...
Merck Stock's Rally Could Extend to Record Highs
Schaeffers Research· 2024-01-08 19:55
The shares of Merck & Co Inc (NYSE:MRK) are already 7.3% higher since the start of the year, and earlier hit a six-month high of $117.89 before turning lower. The pharma stock has been on an uptrend since bouncing off familiar support at the $100 level in late November, and just inched into positive territory year over year. The stock's rally could have legs, too, as its recent highs come amid historically low implied volatility (IV), which has been a bullish combination in the past. Per Schaeffer's Quantit ...
Put Traders Blast Boeing Stock After 737 MAX Incident
Schaeffers Research· 2024-01-08 15:24
Boeing Co (NYSE:BA) stock was last seen down 8.9% at $226.73 and dragging the Dow Jones Industrial Average (DJI) lower, after the U.S Federal Aviation Administration (FAA) temporarily grounded some 737 MAX 9 jets that are fitted with a panel that flew off during an Alaska Air Group (ALK) flight. Airline stocks are struggling as a result, after cancelling over 200 flights.The equity is trading at its lowest level in more than one month, and eyeing its worst single-day percentage drop since May 202. Shares co ...
Pharma Stock Surges on New Drug Partnerships
Schaeffers Research· 2024-01-04 19:41
Stocks are fighting tooth and nail to stay in positive territory today, as the sluggish start to 2024 continues. Notable movers today include self-driving tech stock Mobileye Global Inc (NASDAQ:MBLY), drugmaker Novo Nordisk A/S (NYSE:NVO), and tech titan Apple Inc (NASDAQ:AAPL).MBLY was last seen down 26% to trade at $29.38, one of the worst stocks on the Nasdaq Composite (IXIC) today and heading for its worst single-session drop on record. The bear gap comes after the company disclosed fiscal first-quarter ...
Tesla Stock Has Technical Support in Place
Schaeffers Research· 2024-01-04 17:25
Subscribers to Schaeffer's Weekend Trader options recommendation service received this TSLA commentary on Sunday night, along with a detailed options trade recommendation -- including complete entry and exit parameters. Learn more about why Weekend Trader is one of our most popular options trading services.The shares of electric vehicle (EV) powerhouse Tesla Inc (NASDAQ:TSLA) just pulled back to the round $250 level, an area that coincides with its $800 billion market cap. There's additional support from it ...
Eli Lilly Stock Hits Record on Drug Prescription Website
Schaeffers Research· 2024-01-04 15:47
Eli Lilly And Co (NYSE:LLY) today launched LillyDirect, a website that allows consumers with obesity to get prescriptions for its weight-loss drug Zepbound via telehealth, and offers home delivery options. The move stands in direct competition with WW International (WW), which bought telehealth provider Sequence to offer users access to drugs that suppress appetite, such as Novo Nordisk's (NVO) Ozempic and Wegovy.LLY was last seen up 1.6% at $627.50, and earlier surged to a record high of $631.18. Shares ar ...
Micron Stock Looks to Snap Losing Streak After Upgrade
Schaeffers Research· 2024-01-04 15:44
Piper Sandler this morning upgraded semiconductor stock Micron Technology Inc (NASDAQ:MU) to "overweight" from "neutral," with a price-target hike to $95 from $70. Micron stock is up 1.3% at $83.33 at last glance, on track to snap a five-day losing streak and moving back toward its Dec. 26 52-week high of $87.87. This bull note has Piper Sandler joining an overwhelmingly bullish majority. Of the 38 analysts in coverage, 31 carry a "buy" or better rating on MU. Plus, the 12-month consensus price target of $9 ...
Vaccine Stock the Worst to Own in January, Historically
Schaeffers Research· 2024-01-03 19:22
Pfizer Inc (NYSE:PFE) stock moved steadily lower in 2023, closing 11 out of 12 months lower, with March as the only gainer. Though the shares have been on the rise since their Dec. 13 10-year low of $25.76 -- a result of the company's disappointing 2024 forecast -- PFE might not be in the clear just yet. Per data from Schaeffer's Senior Quantitative Analyst Rocky White, Pfizer stock is at the top of the list of the worst stocks to own in January. In the past 10 years, the equity has finished lower eight tim ...